A detailed history of Abrdn PLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Abrdn PLC holds 428,453 shares of DGX stock, worth $58.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
428,453
Previous 401,344 6.75%
Holding current value
$58.7 Million
Previous $55.3 Million 3.06%
% of portfolio
0.11%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$123.78 - $142.11 $3.36 Million - $3.85 Million
27,109 Added 6.75%
428,453 $57 Million
Q4 2023

Jan 31, 2024

BUY
$120.62 - $141.12 $5.58 Million - $6.53 Million
46,288 Added 13.04%
401,344 $55.3 Million
Q3 2023

Nov 06, 2023

BUY
$121.86 - $144.92 $3.11 Million - $3.69 Million
25,495 Added 7.74%
355,056 $43.3 Million
Q2 2023

Jun 20, 2024

BUY
$130.56 - $146.84 $3.07 Million - $3.45 Million
23,488 Added 7.67%
329,561 $46.3 Million
Q2 2023

Aug 04, 2023

BUY
$130.56 - $146.84 $3.07 Million - $3.45 Million
23,488 Added 7.67%
329,561 $46.3 Million
Q1 2023

Jun 20, 2024

BUY
$131.53 - $155.76 $6.68 Million - $7.91 Million
50,810 Added 19.9%
306,073 $43.3 Million
Q1 2023

Apr 28, 2023

BUY
$131.53 - $155.76 $6.68 Million - $7.91 Million
50,810 Added 19.9%
306,073 $43.3 Million
Q4 2022

Jun 20, 2024

SELL
$123.31 - $157.26 $21.4 Million - $27.2 Million
-173,190 Reduced 40.42%
255,263 $39.9 Million
Q4 2022

Feb 09, 2023

BUY
$123.31 - $157.26 $12.1 Million - $15.4 Million
98,199 Added 62.52%
255,263 $39.9 Million
Q3 2022

Nov 10, 2022

BUY
$121.77 - $141.1 $9.31 Million - $10.8 Million
76,467 Added 94.88%
157,064 $19.3 Million
Q2 2022

Aug 05, 2022

BUY
$127.07 - $145.39 $1.34 Million - $1.53 Million
10,529 Added 15.03%
80,597 $10.8 Million
Q1 2022

May 04, 2022

SELL
$129.09 - $164.35 $1.1 Million - $1.4 Million
-8,514 Reduced 10.83%
70,068 $9.75 Million
Q4 2021

Feb 08, 2022

SELL
$140.36 - $173.01 $870,091 - $1.07 Million
-6,199 Reduced 7.31%
78,582 $13.6 Million
Q3 2021

Nov 15, 2021

BUY
$132.95 - $158.0 $650,524 - $773,094
4,893 Added 6.12%
84,781 $12.4 Million
Q2 2021

Aug 10, 2021

SELL
$126.66 - $141.48 $376,053 - $420,054
-2,969 Reduced 3.58%
79,888 $10.5 Million
Q1 2021

May 06, 2021

BUY
$114.63 - $133.34 $1.82 Million - $2.11 Million
15,845 Added 23.65%
82,857 $10.6 Million
Q4 2020

Feb 10, 2021

BUY
$112.7 - $128.05 $737,959 - $838,471
6,548 Added 10.83%
67,012 $7.99 Million
Q3 2020

Oct 21, 2020

SELL
$107.05 - $130.01 $718,519 - $872,627
-6,712 Reduced 9.99%
60,464 $6.92 Million
Q2 2020

Aug 10, 2020

SELL
$73.34 - $122.61 $323,722 - $541,200
-4,414 Reduced 6.17%
67,176 $7.66 Million
Q1 2020

May 13, 2020

SELL
$75.14 - $115.68 $249,389 - $383,941
-3,319 Reduced 4.43%
71,590 $5.75 Million
Q4 2019

Feb 18, 2020

SELL
$100.29 - $107.99 $190,149 - $204,749
-1,896 Reduced 2.47%
74,909 $8 Million
Q3 2019

Nov 13, 2019

SELL
$97.85 - $107.42 $180,631 - $198,297
-1,846 Reduced 2.35%
76,805 $8.22 Million
Q2 2019

Aug 13, 2019

SELL
$85.18 - $101.94 $101,364 - $121,308
-1,190 Reduced 1.49%
78,651 $8.01 Million
Q1 2019

May 14, 2019

BUY
$80.68 - $89.92 $1.65 Million - $1.84 Million
20,435 Added 34.4%
79,841 $7.18 Million
Q4 2018

Feb 12, 2019

SELL
$79.75 - $108.38 $31,501 - $42,810
-395 Reduced 0.66%
59,406 $4.9 Million
Q3 2018

Nov 13, 2018

BUY
$105.42 - $114.99 $362,117 - $394,990
3,435 Added 6.09%
59,801 $6.45 Million
Q2 2018

Aug 09, 2018

BUY
$97.35 - $113.14 $769,941 - $894,824
7,909 Added 16.32%
56,366 $6.2 Million
Q1 2018

May 15, 2018

SELL
$96.42 - $107.88 $705,697 - $789,573
-7,319 Reduced 13.12%
48,457 $4.86 Million
Q4 2017

Feb 12, 2018

SELL
$90.86 - $100.24 $7.85 Million - $8.67 Million
-86,449 Reduced 60.78%
55,776 $5.49 Million
Q3 2017

Nov 14, 2017

BUY
$91.96 - $108.35 $13.1 Million - $15.4 Million
142,225
142,225 $13.3 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.